Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
72.2M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$5.64B
-
Value change
-
+$61.5M
-
Put/Call ratio
-
0.9
-
Number of buys
-
139
-
Number of sells
-
-168
-
Price
-
$78.12
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2022
403 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2022.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.2M shares
of 106M outstanding shares and own 68.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.32M shares), JANUS HENDERSON GROUP PLC (7.46M shares), BlackRock Inc. (5.55M shares), SANDS CAPITAL MANAGEMENT, LLC (4.78M shares), Avoro Capital Advisors LLC (3.14M shares), WELLINGTON MANAGEMENT GROUP LLP (2.68M shares), EcoR1 Capital, LLC (2.07M shares), STATE STREET CORP (2.06M shares), Bank of New York Mellon Corp (1.97M shares), and FMR LLC (1.55M shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.